Sequana Medical AG   Report issue

For profit Phase 1 Phase 2
Founded: Zwijnaarde Belgium (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2016
NCT02448160
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Sequana Medical N.V.

Active Ingredients

Drugs in Phase 2 Trials (1)

dextrose (1 trial)

Drugs in Phase 1 Trials (1)

icodextrin (Extraneal) (1 trial)

Drugs in Other Trials (1)

albumin (Human) (Plasbumin) (1 trial)

Indications

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3